• Bradford Protein Assay Kit: Practical Workflow

  2026-08-27

  The Bradford Protein Assay Kit (K4103) provides a fast colorimetric method for protein concentration measurement from small sample volumes. It is suited to routine protein quantification in compatible buffers, but samples containing substantial detergent or unusual buffer components require validation before use.

• ER Stress, GRP78/ATF6/CHOP, and Intestinal Stem Cells

  2026-08-27

  This version 1 study links tunicamycin-induced endoplasmic reticulum stress with intestinal stem-cell depletion, impaired epithelial differentiation, reduced crypt proliferation, and increased apoptosis in mice. Its main contribution is a connected model in which GRP78/ATF6/CHOP activation and p44/42 MAPK inhibition accompany damage to the small-intestinal stem-cell niche and barrier.

• ER-Fusogenic Liposomes Strengthen Antitumor Vaccines

  2026-08-26

  The reference study introduces phosphatidylinositol-based immunomodulatory nanoliposomes that combine intrinsic adjuvant activity with endoplasmic-reticulum membrane fusion. In murine models, OVA-loaded PI-INLs enhanced CD8 T-cell responses and tumor protection relative to MF59-adjuvanted OVA, supporting a self-adjuvanting strategy for cellular cancer vaccines.

• Cy5.5 NHS ester for Nanoplatform Imaging

  2026-08-26

  Cy5.5 NHS ester (non-sulfonated) turns amine-bearing proteins, peptides, oligonucleotides, and nanocarriers into trackable near-infrared probes. This workflow shows how to use it to map ultrasound-responsive piezoelectric platforms while preserving a clear distinction between biodistribution data and evidence of neuromodulation.

• Dronedarone (Multaq) in AF Research Workflows

  2026-08-25

  Translate Dronedarone pharmacology into reproducible ion-channel, exposure, and atrial arrhythmia assays. This workflow emphasizes solvent control, therapeutic-range benchmarking, and the KCa2 channel findings that distinguish direct evidence from testable research hypotheses.

• Prion-Based Mutagenesis and Rapid Adaptation

  2026-08-25

  The Cell study shows that prion-like self-assembly of DNA repair and recombination proteins can reversibly and heritably tune mutagenesis, helping fungal populations adapt under strong selection. Its cross-species evidence links prion maintenance to drug resistance and provides a framework for studying how epigenetic memory reshapes genome stability.

• Sulforaphane Attenuates PM2.5-Driven COPD

  2026-08-24

  The reference study integrates rat and cell models with network pharmacology, molecular docking, and pathway perturbation to show that sulforaphane mitigates PM2.5-associated COPD features through Nrf2 activation and suppression of EGFR/PI3K/AKT signaling. Its design provides a useful framework for connecting redox measurements with inflammation, mucus production, tissue injury, and pathway-level validation.

• Antipyrine in BBB Permeability Workflows

  2026-08-23

  Antipyrine combines high aqueous solubility with research-grade purity, making it a practical comparator for transport, recovery, and exposure workflows. This guide shows how to integrate it into LLC-PK1-MOCK/MDR1 assays while avoiding false permeability signals caused by barrier failure, precipitation, or intracellular trapping.

• Deferiprone B1723: Reliable Iron Chelation

  2026-08-22

  Learn how Deferiprone (SKU B1723) can improve the design and interpretation of iron-dependent viability, proliferation, and cytotoxicity assays. This scenario-based guide connects formulation, exposure planning, metabolic readouts, and vendor selection with current enterocyte and cancer biology evidence.

• p-Cresyl Sulfate Drives Aortic Valve Calcification

  2026-08-21

  The reference study identifies p-cresyl sulfate as a direct enhancer of calcification in porcine aortic valvular interstitial cells and connects this effect to HIF-1α, klotho, SIRT1, NF-κB, and RUNX2 signaling. Its combined cell and rat-model design suggests that restoring klotho or activating SIRT1 may attenuate uremic toxin-associated calcific aortic valve disease, while also defining important limits for translation.

• TEAD, Ferroptosis, and HCC: Insights from Ren et al.

  2026-08-21

  Ren et al. combined public-dataset analysis with in vitro validation to identify TEAD2 and TEAD4 as dysregulated in hepatocellular carcinoma, with TEAD2 linked to ferroptosis resistance and unfavorable clinical outcomes. The study provides a useful framework for connecting Hippo-pathway transcriptional regulation with iron-dependent oxidative cell death, while also highlighting the need for functional and clinical validation.

• Danazol and the HPG Axis: A Model-Selection Guide

  2026-08-20

  Danazol research is best interpreted through a model-selection lens. This article connects Danocrine pharmacology with the 2025 rat study of precocious puberty, showing how paired models and mechanistically aligned endpoints improve endocrine assay decisions.

• GDC-0994: ERK1/2 Inhibitor Workflows

  2026-08-20

  GDC-0994 enables direct interrogation of ERK1/2 signaling in BRAF- or RAS-driven cancer models and in mechanistic cholestasis assays. This guide combines pathway validation, concentration-response design, zebrafish rescue experiments, and troubleshooting for more interpretable ERK phosphorylation inhibition.

• Pregnancy LNP Design Shapes mRNA Potency and Safety

  2026-08-19

  This PNAS study shows that lipid nanoparticle architecture and administration route jointly determine mRNA expression, inflammatory signaling, placental immune responses, and postnatal growth in pregnant mice. Its central practical contribution is a mechanism-based framework for optimizing maternal delivery while treating immunogenicity and fetal safety as linked design variables.

• D-Lin-MC3-DMA for RNA LNP Delivery

  2026-08-19

  Dlin-MC3-DMA is an ionizable cationic liposome lipid used in siRNA and mRNA lipid nanoparticle workflows. Product data report high potency for hepatic gene silencing, while a 2025 study shows how systematic LNP screening and machine learning can optimize mRNA immunomodulation without proving A8791-specific performance.

457 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page